Millennium Management
TTPH

Millennium Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Millennium Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,500
Closed -$224K – 3913
2015
Q3 		$224K Sell
1,500
-2,550
-63% -$1.87M ﹤0.01% 3068
2015
Q2 		$3.84M Buy
+4,050
New +$3.31M 0.01% 1546

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management's TTPH Position: Q3 2019 in Review

Millennium Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 26,136 shares — an estimated $251K sold.

Millennium Management first reported a position in TTPH in Q4 2013 and held it in 22 quarters. The position peaked at $22M in Q4 2014. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Millennium Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Millennium Management sold 26,136 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $251K.
  • Millennium Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2013 and held it in 22 quarters.
  • Millennium Management's Tetraphase Pharmaceuticals, Inc. position peaked at $22M in Q4 2014.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Millennium Management's 13F filing for Q3 2019, filed 14 Nov 2019.